Saturday 17 October 2026
Export ALB’s income statement to Excel — free account
Albemarle Corporation
ALB Basic Materials Specialty Chemicals
Albemarle Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, down 4.37% from fiscal 2024. In the quarter to June 2026, revenue grew 31.1%, EPS grew 2,425.0%, free cash flow grew 708.4% and total debt fell 48.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
95.48
2.70
−2.75%
Follow ALB
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 281.31 |
P/S ratio |
1.93 | 3.24 | 3.85 | 2.70 | |
P/FCF ratio |
57.16 | 22.95 | 34.78 | 11.79 | |
P/Operating CF |
26.83 | 42.84 | 61.11 | 22.43 | |
P/B ratio |
1.19 | 2.21 | 2.69 | 1.92 | |
Price to Tangible BV |
1.51 | 2.85 | 3.43 | 2.41 | |
EV/Sales |
2.27 | 3.54 | 3.99 | 2.74 | |
EV/EBITDA |
16.19 | 38.54 | 32.16 | 15.05 | |
EV/Operating CF |
12.63 | 14.21 | 20.30 | 8.98 | |
EV/FCF |
67.31 | 25.12 | 36.09 | 11.97 | |
Quick Ratio |
1.38 | 1.29 | 1.11 | 1.25 | |
Current Ratio |
2.27 | 2.23 | 2.07 | 2.09 | |
Net Debt/EBITDA |
13.18 | (29.35) | 2.02 | 0.40 | |
Debt/Assets |
21.15% | 19.50% | 12.43% | 11.80% | |
Debt/Equity |
0.35 | 0.33 | 0.19 | 0.18 | |
Asset Turnover |
0.29 | 0.31 | 0.34 | 0.36 | |
Operating CF/Net income |
(1.76) | (0.85) | 1.25 | 1.62 | |
Capex/Depreciation |
(0.38) | (0.91) | (0.63) | (0.46) | |
Interest Coverage |
(4.26) | (3.76) | 7.05 | 14.65 | |
Research and Development Expense of Revenue |
0.97% | 0.85% | 0.64% | 0.21% | |
Selling, General and Administrative Expense of Revenue |
10.60% | 10.89% | 9.62% | 7.25% | |
Intangible Assets out of Total Assets |
0.10 | 0.10 | 0.11 | 0.11 | |
Share Based Compensation of Revenue |
0.84% | 0.86% | 0.55% | 0.39% | |
Graham Net Nets |
(0.24) | (0.16) | (0.08) | (0.09) | |
Graham Number |
0.00 | 0.00 | 0.00 | 27.56 | |
Earnings Yield |
(1.96%) | (4.07%) | (1.89%) | 0.36% | |
Free Cash Flow Yield |
1.75% | 4.36% | 2.87% | 8.48% | |
Revenue per Share |
11.11 | 12.14 | 12.12 | 14.78 | |
Operating CF per Share |
3.02 | 3.30 | 2.94 | 6.02 | |
Capex per Share |
(1.11) | (1.26) | (0.84) | (0.61) | |
Free Cash Flow per Share |
1.91 | 2.04 | 2.10 | 5.41 | |
Cash per Share |
16.41 | 13.75 | 9.25 | 13.83 | |
Shareholders Equity per Share |
87.26 | 83.13 | 85.77 | 89.30 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
87.26 | 83.13 | 85.77 | 89.30 | |
Free Cash Flow |
225.34 | 240.26 | 247.57 | 638.27 | |
Working Capital |
2,550.95 | 2,210.10 | 1,683.25 | 2,053.10 | |
Capital Expenditures |
(130.26) | (148.22) | (98.68) | (71.73) | |
Net Current Asset Value |
(2,324.32) | (2,584.61) | (1,772.28) | (1,427.04) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 64.16 | |
Capex to Sales |
0.10 | 0.10 | 0.07 | 0.04 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 63.19 | |
| Other line items | |||||
Average Receivables |
929.83 | 839.60 | 733.67 | 803.71 | |
Average Payables |
1,313.46 | 928.71 | 925.87 | 987.22 | |
Average Inventory |
1,595.16 | 1,340.90 | 1,501.66 | 1,512.74 | |
Average Assets |
17,301.74 | 16,491.93 | 16,069.42 | 16,598.51 | |
Average Common Equity |
8,144.75 | 7,755.47 | 7,956.12 | 8,281.31 |
Columns are period end dates